Indefinite Delivery Contract 75N95024D00039
Award Date
9/27/24
Last Date to Order
9/26/28
Funding Federal Agency
National Institute of Mental Health
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
National Medical Services, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV, awarded by the Defense Health Agency (DHA) to National Medical Services, Inc. (doing business as NMS Labs), is for the provision of quantitative testing services. The single-award, $118,248 indefinite delivery contract has a period of performance running from September 15, 2020, through September 14, 2025. The contract originated from a solicitation seeking forensic toxicology testing services that the Division of Forensic Toxicology (DTF) was unable to provide...
This indefinite delivery contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to the Research Foundation for Mental Hygiene, Inc. (RFMH) doing business as RFMH. The single-award IDC has a ceiling value of $1,749,352.30 and a period of performance ending on June 30, 2013. The purpose of this IDC is to provide funding and support for an MTA (Mental Health...
The National Academy of Sciences (NAS), a private non-profit organization, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Institute of Mental Health, a civilian agency, to provide studies, program analyses, and other similar convenings to support the NIH's mission of seeking fundamental knowledge about the nature and behavior of living systems and the application of that knowledge. The contract has a ceiling value of $67,623,709.79 and a period of...
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to New York University (NYU) School of Medicine. The $898,929.74 contract provides funding for an MTA (Mental Health Services Study) study under the DSIR (Drug Dependence Epidemiology Research) program. As an IDC, this contract provides a flexible mechanism for NIDA to issue task...
The National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a $6.5 million single-award Indefinite Delivery Contract (IDC) to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization, to assess potential treatments for drug-induced respiratory depression and overdose toxicity. The contract has a period of performance from September 26, 2022 to September 25, 2027. Under this IDC, NIDA has issued several cost-plus-fixed-fee delivery...
This indefinite delivery contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $9.75 million IDC has a period of performance from September 12, 2023 to September 11, 2028 and is for toxicological evaluations of potential medications to support NIDA's mission. Under this IDC, Sri International has been awarded two task orders so far....
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center. Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The...
This indefinite delivery contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $48.6 million multiple-award IDC has a 6-year ordering period from June 2024 to June 2030. The contract aims to procure safety evaluation and toxicology studies and related services to support drug development efforts at NCATS....
The National Institute on Drug Abuse (NIDA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, to maintain and expand the NIDA Center for Genetic Studies (NCGS) over a 5-year period. The $15,000,000 contract aims to create a repository to receive, process, and store de-identified biospecimens and associated clinical and phenotypic data from NIDA-funded genetic addiction research, and to make these resources widely available to...